October 16, 2025

Comprehensive Review Identifies Key Neonatal Death Risks

Review grades evidence on neonatal mortality across 64 reviews; methods and gaps outlined.

Conexiant

October 08, 2025

Tracking Residual Disease in Myeloma With Flow Cytometry

Multiparameter flow cytometry enables measurable residual disease testing and prognosis in patients with multiple myeloma

The Pathologist

October 06, 2025

Pathology Meets Play: The Video Game That Trains Your Diagnostic Eye

Learning to identify clues in unexpected places prepared me for real-world diagnosis at the microscope

The Pathologist

October 03, 2025

From Agent Orange to PCBs: Lessons for Care

Air Force reviews cancer risk in missile crews; early analyses show no excess mortality, but exposures to PCBs and benzene prompt vigilance and targeted histories.

KFF Health News

October 02, 2025

Distal vs Shaft Tibia Fractures in Children

Open distal tibia fractures in pediatric patients are more severe than shaft fractures.

Conexiant

September 24, 2025

When High Hospital Prices Mean Higher Risk

High-markup hospitals, often for-profit, were tied to higher surgical risks, with commentary calling for transparency and oversight.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

February 12, 2025

FDA & EMA: Submitted Trial Data Discrepancies

Sample size discrepancies were identified in 13 trials (65%), with 8 differing by more than 10%.

Conexiant

March 21, 2025

Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy

The FDA approves vutrisiran (Amvuttra) as the first RNAi therapeutic to reduce cardiovascular events and mortality in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

Conexiant